Minireview : Gene methylation in thyroid tumorigenesisMINGZHAO XING.Endocrinology (Philadelphia). 2007, Vol 148, Num 3, pp 948-953, issn 0013-7227, 6 p.Article

The T1799A BRAF mutation is not a germline mutation in familial nonmedullary thyroid cancerMINGZHAO XING.Clinical endocrinology (Oxford. Print). 2005, Vol 63, Num 3, pp 263-266, issn 0300-0664, 4 p.Article

BRAF Mutation in Papillary Thyroid Cancer : Pathogenic Role, Molecular Bases, and Clinical ImplicationsMINGZHAO XING.Endocrine reviews. 2007, Vol 28, Num 7, pp 742-762, issn 0163-769X, 21 p.Article

Anaplastic Thyroid Cancers Harbor Novel Oncogenic Mutations of the ALK GeneAVANIYAPURAM KANNAN MURUGAN; MINGZHAO XING.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 13, pp 4403-4411, issn 0008-5472, 9 p.Article

Phosphorylation-dependent regulation of phospholipase A₂ by G-proteins and Ca²⁺ in HL60 granulocytesMINGZHAO XING; MATTERA, R.The Journal of biological chemistry (Print). 1992, Vol 267, Num 36, pp 25966-25975, issn 0021-9258Article

BRAF mutation-selective inhibition of thyroid cancer cells by the novel MEK inhibitor RDEA119 and genetic-potentiated synergism with the mTOR inhibitor temsirolimusDINGXIE LIU; JOANNA XING; TRINK, Barry et al.International journal of cancer (Print). 2010, Vol 127, Num 12, pp 2965-2973, issn 0020-7136, 9 p.Article

BRAF V600E maintains proliferation, transformation, and tumorigenicity of braf-mutant papillary thyroid cancer cellsDINGXIE LIU; ZHI LIU; CONDOURIS, Stephen et al.The Journal of clinical endocrinology and metabolism. 2007, Vol 92, Num 6, pp 2264-2271, issn 0021-972X, 8 p.Article

Progress in molecular-based management of differentiated thyroid cancerMINGZHAO XING; HAUGEN, Bryan R; SCHLUMBERGER, Martin et al.Lancet (British edition). 2013, Vol 381, Num 9871, pp 1058-1069, issn 0140-6736, 12 p.Article

Association of PTEN Gene Methylation With Genetic Alterations in the Phosphatidylinositol 3-Kinase/AKT Signaling Pathway in Thyroid TumorsPENG HOU; MEIJU JI; MINGZHAO XING et al.Cancer. 2008, Vol 113, Num 9, pp 2440-2447, issn 0008-543X, 8 p.Article

Induction of Thyroid Gene Expression and Radioiodine Uptake in Thyroid Cancer Cells by Targeting Major Signaling PathwaysPENG HOU; BOJDANI, Ermal; MINGZHAO XING et al.The Journal of clinical endocrinology and metabolism. 2010, Vol 95, Num 2, pp 820-828, issn 0021-972X, 9 p.Article

Regulation of phospholipase A₂ activity in undifferentiated and neutrophil-like HL60 cells : linkage between impaired responses to agonists and absence of protein kinase C-dependent phosphorylation of cytosolic phospholipase A₂MINGZHAO XING; WILKINS, P. L; MCCONNELL, B. K et al.The Journal of biological chemistry (Print). 1994, Vol 269, Num 4, pp 3117-3124, issn 0021-9258Article

Genetic Alterations in the Phosphoinositide 3-Kinase/Akt Signaling Pathway Confer Sensitivity of Thyroid Cancer Cells to Therapeutic Targeting of Akt and Mammalian Target of RapamycinDINGXIE LIU; PENG HOU; ZHI LIU et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 18, pp 7311-7319, issn 0008-5472, 9 p.Article

Lack of Mutations in the Thyroid Hormone Receptor (TR) a and β Genes but Frequent Hypermethylation of the TRβ Gene in Differentiated Thyroid TumorsJOSEPH, Biju; MEIJU JI; DINGXIE LIU et al.The Journal of clinical endocrinology and metabolism. 2007, Vol 92, Num 12, pp 4766-4770, issn 0021-972X, 5 p.Article

Inhibitory Effects of the Mitogen-Activated Protein Kinase Kinase Inhibitor CI-1040 on the Proliferation and Tumor Growth of Thyroid Cancer Cells with BRAF or RAS MutationsDINGXIE LIU; ZHI LIU; JIANG, David et al.The Journal of clinical endocrinology and metabolism. 2007, Vol 92, Num 12, pp 4686-4695, issn 0021-972X, 10 p.Article

IOGAP1 Plays an Important Role in the Invasiveness of Thyroid CancerZHI LIU; DINGXIE LIU; BOJDANI, Ermal et al.Clinical cancer research (Print). 2010, Vol 16, Num 24, pp 6009-6018, issn 1078-0432, 10 p.Article

Suppression of BRAF/MEK/MAP kinase pathway restores expression of iodide-metabolizing genes in thyroid cells expressing the V600E braf mutantDINGXIE LIU; SHUIYING HU; PENG HOU et al.Clinical cancer research. 2007, Vol 13, Num 4, pp 1341-1349, issn 1078-0432, 9 p.Article

Identification of RASAL1 as a Major Tumor Suppressor Gene in Thyroid CancerDINGXIE LIU; CHONGFEI YANG; BOJDANI, Ermal et al.Journal of the National Cancer Institute. 2013, Vol 105, Num 21, pp 1617-1627, issn 0027-8874, 11 p.Article

Association of High Iodine Intake with the T1799A BRAF Mutation in Papillary Thyroid CancerHAIXIA GUAN; MEIJU JI; RONG BAO et al.The Journal of clinical endocrinology and metabolism. 2009, Vol 94, Num 5, pp 1612-1617, issn 0021-972X, 6 p.Article

Hypermethylation of the DNA Mismatch Repair Gene hMLH1 and Its Association With Lymph Node Metastasis and T1799A BRAF Mutation in Patients With Papillary Thyroid CancerHAIXIA GUAN; MEIJU JI; PENG HOU et al.Cancer. 2008, Vol 113, Num 2, pp 247-255, issn 0008-543X, 9 p.Article

Selective Growth Inhibition in BEAT Mutant Thyroid Cancer by the Mitogen-Activated Protein Kinase Kinase 1/2 Inhibitor AZD6244BALL, Douglas W; NING JIN; ROSEN, D. Marc et al.The Journal of clinical endocrinology and metabolism. 2007, Vol 92, Num 12, pp 4712-4718, issn 0021-972X, 7 p.Article

Early occurrence of RASSF1A hypermethylation and its mutual exclusion with BRAF mutation in thyroid tumorigenesisMINGZHAO XING; COHEN, Yoram; MAMBO, Elizabeth et al.Cancer research (Baltimore). 2004, Vol 64, Num 5, pp 1664-1668, issn 0008-5472, 5 p.Article

High prevalence and possible de Novo formation of BRAF mutation in metastasized papillary thyroid cancer in lymph nodesVASKO, Vasily; SHUIYING HU; GUOJUN WU et al.The Journal of clinical endocrinology and metabolism. 2005, Vol 90, Num 9, pp 5265-5269, issn 0021-972X, 5 p.Article

Tumor-specific changes in mtDNA content in human cancerMAMBO, Elizabeth; CHATTERJEE, Aditi; MINGZHAO XING et al.International journal of cancer. 2005, Vol 116, Num 6, pp 920-924, issn 0020-7136, 5 p.Article

Mitochondrial DNA Alterations in thyroid cancerTONG, Betty C; HA, Patrick K; DHIR, Karan et al.Journal of surgical oncology. 2003, Vol 82, Num 3, pp 170-173, issn 0022-4790, 4 p.Article

Highly Prevalent Genetic Alterations in Receptor Tyrosine Kinases and Phosphatidylinositol 3-Kinase/Akt and Mitogen-Activated Protein Kinase Pathways in Anaplastic and Follicular Thyroid CancersZHI LIU; PENG HOU; MEIJU JI et al.The Journal of clinical endocrinology and metabolism. 2008, Vol 93, Num 8, pp 3106-3116, issn 0021-972X, 11 p.Article